{
  "slug": "sickle-cell-crisis",
  "question": "What are the odds of having sickle cell disease?",
  "quick_answer": "Sickle cell disease occurs in about 1 in 365 Black or African American births in the US, and roughly 1 in 2,070 across all races. It is generally underestimated by the broad public, who recall the term from biology class but rarely the actual prevalence.\n",
  "category": "health",
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Sickle cell disease occupies a peculiar informational niche: well known as a textbook example of Mendelian genetics, poorly understood in terms of actual prevalence. Most Americans can recall the phrase \"sickle cell\" from a biology class but would struggle to distinguish trait from disease or estimate how many people are affected. Among Black Americans, awareness tends to be higher but still imprecise — many know someone with the trait but fewer grasp the 1-in-365 birth prevalence of the disease itself. No large-scale survey isolates \"fear of having sickle cell disease\" as a distinct item, so the perceived estimate here relies on editorial judgment informed by public-health literacy research.\n",
    "rough_estimate": "generally underestimated by the broad public; somewhat better known in affected communities",
    "kind": "intuition"
  },
  "native": {
    "display": "~1 in 365 Black or African American births in the US",
    "numerator": 1,
    "denominator": 365,
    "unit": "per birth",
    "population": "Black or African American newborns in the US"
  },
  "normalized": {
    "lifetime_us_adult": 0.00274,
    "display": "~1 in 365 (subgroup birth prevalence)",
    "log_value": -2.56,
    "assumptions": "CDC reports SCD occurs in approximately 1 out of every 365 Black or African American births. The 2016–2020 Sickle Cell Data Collection program across 11 states found a crude prevalence of 28.54 per 10,000 non-Hispanic Black newborns (approximately 1 in 350), broadly consistent with the established 1-in-365 figure. Because SCD is a genetic condition present at birth, the \"lifetime probability\" is simply the birth prevalence for the affected subgroup: 1/365 ≈ 0.00274. This is not annualized or compounded — it is the probability that a Black American newborn will have SCD. For the overall US population (all races), the birth prevalence is approximately 4.83 per 10,000 (1 in 2,070). The normalized figure here uses the subgroup-specific rate because the condition is overwhelmingly concentrated in this population.\n",
    "uncertainty": {
      "low": 0.0025,
      "high": 0.003
    },
    "scope": "subgroup_lifetime"
  },
  "sources": [
    {
      "url": "https://www.cdc.gov/sickle-cell/data/index.html",
      "title": "Data and Statistics on Sickle Cell Disease",
      "publisher": "Centers for Disease Control and Prevention",
      "source_type": "govt_report",
      "statistic": "SCD affects approximately 100,000 Americans; occurs in about 1 in 365 Black or African American births and 1 in 16,300 Hispanic American births",
      "excerpt": "\"SCD affects approximately 100,000 Americans. SCD occurs among about 1 out of every 365 Black or African American births. SCD occurs among about 1 out of every 16,300 Hispanic-American births. Sickle cell trait (SCT) occurs among about 1 in 13 Black or African American babies.\"\n",
      "source_date": "2024-05-15",
      "source_accessed": "2026-04-18",
      "archive_url": "https://web.archive.org/web/20260424190035/https://www.cdc.gov/sickle-cell/data/index.html",
      "calculation_notes": "CDC reports 1 in 365 Black/African American births have SCD. This yields a birth prevalence of 1/365 ≈ 0.002740. The 100,000 affected Americans figure is consistent with ~45 million Black Americans × 0.00274 prevalence, accounting for reduced life expectancy in SCD patients (median survival ~54 years vs ~77 years general population). No annualization needed — SCD is a congenital condition, so birth prevalence equals lifetime prevalence for the subgroup.\n"
    },
    {
      "url": "https://www.cdc.gov/mmwr/volumes/73/wr/mm7312a1.htm",
      "title": "Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability — Sickle Cell Data Collection Program, 11 States, 2016–2020",
      "publisher": "CDC Morbidity and Mortality Weekly Report",
      "source_type": "govt_report",
      "statistic": "SCD birth prevalence of 28.54 per 10,000 (1 in 350) among non-Hispanic Black newborns across 11 states, 2016–2020",
      "excerpt": "\"During 2016–2020, a total of 3,305 confirmed SCD cases were identified among newborns in 11 states. The crude SCD birth prevalence was 4.83 per 10,000 live births overall and 28.54 per 10,000 among non-Hispanic Black newborns.\"\n",
      "source_date": "2024-03-28",
      "source_accessed": "2026-04-18",
      "archive_url": "https://web.archive.org/web/20260426211512/https://www.cdc.gov/mmwr/volumes/73/wr/mm7312a1.htm",
      "calculation_notes": "The MMWR study uses newborn screening data from 11 states participating in the Sickle Cell Data Collection program. The non-Hispanic Black birth prevalence of 28.54 per 10,000 equals 1 in 350, slightly higher than the traditionally cited 1 in 365. The difference likely reflects improved screening sensitivity and updated population denominators. The overall US birth prevalence of 4.83 per 10,000 (1 in 2,070) reflects dilution across all racial/ethnic groups. Both figures are consistent within expected variation.\n"
    },
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/20331952/",
      "title": "Population estimates of sickle cell disease in the U.S.",
      "publisher": "American Journal of Preventive Medicine",
      "source_type": "peer_reviewed",
      "statistic": "Estimated US SCD population of 72,000–98,000 (mortality-corrected), may approach 100,000 (2008)",
      "excerpt": "\"National SCD population estimates ranged from 104,000 to 138,900, based on birth-cohort disease prevalence, but from 72,000 to 98,000 when corrected for early mortality. The number of individuals with SCD in the U.S. may approach 100,000, even when accounting for the effect of early mortality on estimations.\"\n",
      "source_date": "2010-06-01",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260319000406/https://pubmed.ncbi.nlm.nih.gov/20331952/",
      "calculation_notes": "Hassell (2010) used newborn screening data and survival estimates to compute population prevalence. The mortality-corrected estimate for 2008 was 72,000–98,000 (104,000–138,900 before correcting for early mortality), and the paper concludes the true number \"may approach 100,000.\" This is broadly consistent with the current CDC figure of ~100,000 affected Americans, reflecting improved survival (hydroxyurea, penicillin prophylaxis, transfusion therapy) and immigration from SCD-prevalent regions. This source supports the ~100,000-prevalence headline; the 1-in-365 birth prevalence is cited separately to CDC newborn-screening data above.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Cystic fibrosis birth prevalence (white Americans)",
      "lifetime_us_adult": 0.00029
    },
    {
      "label": "Down syndrome birth prevalence (all US births)",
      "lifetime_us_adult": 0.00125
    },
    {
      "label": "Phenylketonuria birth prevalence (all US births)",
      "lifetime_us_adult": 0.0000625
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Black or African American",
      "multiplier": 1,
      "notes": "Baseline subgroup — 1 in 365 births"
    },
    {
      "factor": "Hispanic American",
      "multiplier": 0.022,
      "notes": "~1 in 16,300 births"
    },
    {
      "factor": "White American (non-Hispanic)",
      "multiplier": 0.001,
      "notes": "Extremely rare; estimated <1 in 100,000 births"
    },
    {
      "factor": "West African or West-African-descent ancestry (vs US Black average)",
      "multiplier": 1.3,
      "notes": "WHO and CDC data show HbS allele carrier frequency of 20-30% in parts of West Africa (Nigeria, Ghana, Cameroon) compared to roughly 8% (1 in 13) in the US Black population, reflecting migration-pattern averaging; individuals with recent West African ancestry face somewhat higher birth prevalence than the US Black average"
    },
    {
      "factor": "both parents confirmed sickle cell trait carriers",
      "multiplier": 91,
      "notes": "Mendelian genetics: when both parents carry HbAS (sickle cell trait, 1-in-13 prevalence among Black Americans per CDC), each pregnancy has a 1-in-4 chance of SCD — approximately 25%, versus the population baseline of ~0.274% (1 in 365); ratio is approximately 91x the population rate"
    }
  ],
  "short_label": "Sickle cell disease",
  "myth_framing": "calibrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "recurring",
  "outcome_type": "chronic_illness",
  "valence": "negative",
  "caveats": "Sickle cell disease is a genetic condition, not an acquired risk — the \"probability\" here is birth prevalence, not an annual hazard rate. It is determined entirely by parental genotype. The 1-in-365 figure applies specifically to Black or African American newborns; for the overall US population (all races), birth prevalence is roughly 1 in 2,070. Sickle cell trait (carrying one copy of the gene) is far more common — about 1 in 13 Black Americans — but trait carriers generally do not develop the disease. SCD prevalence also varies by specific ancestry within the African diaspora, with higher rates among those with West African heritage. Life expectancy for SCD patients has improved significantly with hydroxyurea and other therapies but remains substantially below the general population average.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 3,
    "d8": 5,
    "avg": 4.625,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "quality-review-agent",
  "last_reviewed": "2026-04-19",
  "reviewed": true,
  "generated_at": "2026-04-18",
  "image": {
    "alt": "Abstract crescent shapes in red and muted tones, flat editorial illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/sickle-cell-crisis"
}